drugset / Trial / NCT02408146
The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection
RandomizedParallel-groupDouble-blindTreatment
Summary
The investigators hypothesized that using new intravenous infusion pump of patient-controlled analgesia (parecoxib sodium 1 mg/mL + normal saline) would significantly improve postoperative pain control compare to conventional intravenous infusion pump of patient-controlled analgesia (fentanyl citrate 20 mg/mL/kg + ondansetron hydrochloride 16 mg/8 mL + normal saline). This prospective randomized controlled trial was designed to evaluate the benefit of new intravenous infusion pump of patient-controlled analgesia (parecoxib sodium 1 mg/mL + normal saline) for postoperative analgesia after laparotomic liver resection.
Timeline
- Start
- 2014-01
- Primary completion
- 2015-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 20 unknown | Intravenous |
| Subject | Parecoxib | Small molecule | 1 mg/ml | Intravenous |
| Subject | Parecoxib | Small molecule | 40 mg | Intravenous |
| Background | Celecoxib | Other / unclassified | — | Oral |
| Background | Ondansetron | Other / unclassified | 16 mg | Intravenous |